U. Vahlensieck

发表

Identification and characterization of diadenosine 5′,5‴‐P1,P2‐diphosphate and diadenosine 5′,5‴‐P1,P3‐triphosphate in human myocardial tissue

H. Schlüter, J. Jankowski, W. Schmitz, 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Quantification of the cAMP response element binding protein in ventricular nuclear protein from failing and nonfailing human hearts.

H. Scheld, M. Böhm, F. Müller, 1997, Biochemical and biophysical research communications.

cAMP response element binding protein is expressed and phosphorylated in the human heart.

H. Scheld, M. Böhm, F. Müller, 1995, Circulation.

Metabolism of caffeic acid in the isolated perfused rat liver.

U. Vahlensieck, H. Winterhoff, H. Gumbinger, 1993, Planta medica.

Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases.

F. Müller, W. Schmitz, G. Bodor, 1998, American journal of physiology. Heart and circulatory physiology.

On the Cardiac Contractile, Electrophysiological and Biochemical Effects of Endothall, a Protein Phosphatase Inhibitor

S. Huke, F. Müller, W. Schmitz, 2000, Pharmacology.

Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations.

S. Huke, H. Scheld, H. Schlüter, 1999, The Journal of pharmacology and experimental therapeutics.

Functional studies in atrium overexpressing A1‐adenosine receptors

F. Müller, W. Schmitz, G. Matherne, 1999, British journal of pharmacology.

Identification and expression of a novel isoform of cAMP response element modulator in the human heart

H. Scheld, E. Oetjen, F. Müller, 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

On the contractile function of protein phosphatases in isolated human coronary arteries

S. Huke, H. Scheld, F. Müller, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability.

S. Huke, F. Müller, W. Schmitz, 1999, The Journal of pharmacology and experimental therapeutics.

Contractility and inhibition of protein phosphatases by cantharidin.

S. Huke, F. Müller, W. Schmitz, 1998, General pharmacology.

The mechanism of action of cantharidin in smooth muscle

S. Huke, F. Müller, W. Schmitz, 1998, British journal of pharmacology.

Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts

F. Müller, W. Schmitz, J. Neumann, 1996, British journal of pharmacology.

Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species.

F. Müller, W. Schmitz, L. Jones, 1999, Journal of molecular and cellular cardiology.

In vivo isoproterenol treatment leads to downregulation of the mRNA encoding the cAMP response element binding protein in the rat heart.

F. Müller, W. Schmitz, P. Bokník, 1995, Biochemical and biophysical research communications.

Negative chronotropic and inotropic effects exerted by diadenosine hexaphosphate (AP6A) via A1‐adenosine receptors

H. Scheld, H. Schlüter, F. Müller, 1996, British journal of pharmacology.

Quantitation of clobazam in human plasma using high-performance liquid chromatography.

F. Müller, W. Schmitz, J. Neumann, 1999, Journal of chromatographic science.

Inotropic effects of diadenosine tetraphosphate in isolated canine cardiac preparations.

H. Schlüter, F. Müller, W. Schmitz, 1999, Journal of cardiovascular pharmacology.

The effect of Chelidonium majus herb extract on choleresis in the isolated perfused rat liver.

A. Nahrstedt, F. H. Kemper, U. Vahlensieck, 1995, Planta medica.

Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases.

W. Schmitz, T. Muller, G. Bodor, 1998, The American journal of physiology.

Endocrine effects of Lycopus europaeus L. following oral application.

H. Schmitz, F. H. Kemper, B. Behnke, 1994, Arzneimittel-Forschung.

Regional expression of phospholamban in the human heart.

C. Unkel, F. Müller, W. Schmitz, 1999, Cardiovascular research.

The effect of the protein phosphatases inhibitor cantharidin on β‐adrenoceptor‐mediated vasorelaxation

F. Müller, W. Schmitz, P. Neumann, 1997, British journal of pharmacology.

Mechanisms of the contractile effects of levosimendan in the mammalian heart.

W. Schmitz, H. Scholz, J. Neumann, 1997, The Journal of pharmacology and experimental therapeutics.

Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle.

F. Müller, W. Schmitz, H. Baba, 1998, The Journal of pharmacology and experimental therapeutics.

Analysis of the components of Lycopus europaeus L. in body fluids during metabolism studies. Comparison of capillary electrophoresis and high-performance liquid chromatography.

A. Nahrstedt, H. Wojciechowski, U. Vahlensieck, 1995, Journal of Chromatography A.

Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na(+)-Ca(2+) exchanger.

S. Huke, F. Müller, W. Schmitz, 2000, The Journal of pharmacology and experimental therapeutics.

Inositol-1,4,5-trisphosphate increase by diadenosine tetraphosphate in preparations from failing human myocardium

H. Schlüter, F. Müller, W. Schmitz, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.